Matches in Nanopublications for { ?s ?p "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 18 of
18
with 100 items per page.
- assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP428899.RAXaV84kvaoamgohk5gYFxo6i0nwBSJMoPHpcWKnUGTIM130_assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428899.RAXaV84kvaoamgohk5gYFxo6i0nwBSJMoPHpcWKnUGTIM130_provenance.
- assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP630359.RAe98_U8jNmk4X3QXlT6FiGyd7o4yaETQIm1l1bbTvAOk130_assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630359.RAe98_U8jNmk4X3QXlT6FiGyd7o4yaETQIm1l1bbTvAOk130_provenance.
- NP630362.RAgjgF4B4_0XO0t7JmaBwDJIe3Q69BoeUUd2M0_M69JnM130_assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630362.RAgjgF4B4_0XO0t7JmaBwDJIe3Q69BoeUUd2M0_M69JnM130_provenance.
- NP630363.RAsAiWANRMyHjCDZyfypfFhq9CgEyh-oXLtq35aGIX1Mk130_assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630363.RAsAiWANRMyHjCDZyfypfFhq9CgEyh-oXLtq35aGIX1Mk130_provenance.
- NP416003.RAGRH9srhhHj-1ieTxNFQ3YumrGfy2V_w3KmnJvBcMUD4130_assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416003.RAGRH9srhhHj-1ieTxNFQ3YumrGfy2V_w3KmnJvBcMUD4130_provenance.
- NP815014.RAMnWVLP7CffyFx6Tb3BFQxppblADL3uXe9M9yj3koX2g130_assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815014.RAMnWVLP7CffyFx6Tb3BFQxppblADL3uXe9M9yj3koX2g130_provenance.
- NP815015.RAwU9N_JZTYjk28OvHqJZAtCy8Ikipqz2ugaWdqZDM48A130_assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815015.RAwU9N_JZTYjk28OvHqJZAtCy8Ikipqz2ugaWdqZDM48A130_provenance.
- NP630360.RAy9HIsaif8zXln_y1-czc6UookLxfI47A1mSrJG1ZPbw130_assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630360.RAy9HIsaif8zXln_y1-czc6UookLxfI47A1mSrJG1ZPbw130_provenance.
- NP630361.RA0xTVx88FhBgQlxcS6R783vfnB0OO88sxamNma_lw1BI130_assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630361.RA0xTVx88FhBgQlxcS6R783vfnB0OO88sxamNma_lw1BI130_provenance.
- NP630367.RA6M0kGJ_ke8ZgiXCtbY7eymFv435jxc31bj0OFTaY-GY130_assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630367.RA6M0kGJ_ke8ZgiXCtbY7eymFv435jxc31bj0OFTaY-GY130_provenance.
- NP952194.RA4wxstcAcG0a3joF73o3AHM2pSD7GX0Z7tdQdvF-4a08130_assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952194.RA4wxstcAcG0a3joF73o3AHM2pSD7GX0Z7tdQdvF-4a08130_provenance.
- NP952195.RA_kEUvP2AiHGVKngIrYJGCyer_coymePUck81JubmPpg130_assertion description "[MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP952195.RA_kEUvP2AiHGVKngIrYJGCyer_coymePUck81JubmPpg130_provenance.